CL2009000920A1 -
Use of dronedarone or a pharmaceutically acceptable salt to prepare a drug useful for the prevention of cardiovascular hospitalizations.
- Google Patents
Use of dronedarone or a pharmaceutically acceptable salt to prepare a drug useful for the prevention of cardiovascular hospitalizations.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filedlitigationCriticalhttps://patents.darts-ip.com/?family=43806577&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2009000920(A1)"Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from FR0802127Aexternal-prioritypatent/FR2930148A1/en
Application filed by Sanofi AventisfiledCriticalSanofi Aventis
Publication of CL2009000920A1publicationCriticalpatent/CL2009000920A1/en
Acyclic And Carbocyclic Compounds In Medicinal Compositions
(AREA)
Coloring Foods And Improving Nutritive Qualities
(AREA)
Abstract
Composición farmacéutica de una dosis eficaz de dronedarona o sus sales; artículo de fabricación; un envase; y uso para la prevención de la mortalidad y/o hospitalizaciones cardiovasculares.Pharmaceutical composition of an effective dose of dronedarone or its salts; article of manufacture; a container; and use for the prevention of cardiovascular mortality and / or hospitalizations.
CL2009000920A2008-04-172009-04-16
Use of dronedarone or a pharmaceutically acceptable salt to prepare a drug useful for the prevention of cardiovascular hospitalizations.
CL2009000920A1
(en)
Use of dronedarone to prepare medicament to prevent mortality and/or cardiovascular hospitalizations in patients having e.g. history of atrial fibrillation/atrial flutter, cerebrovascular accident and non-rheumatic valvular heart disease
DRONEDARON APPLICATION FOR THE PREPARATION OF A MEDICINE FOR THE APPLICATION IN THE PREVENTION OF HOSPITALIZATION IN THE CARDIOLOGICAL DEPARTMENT OR MORTALITY
Use of a pharmaceutical composition comprising treprostinil for the preparation of a medicament for the treatment or prevention of a condition associated with cystic fibrosis.
USE OF DRONEDARONE OR A PHARMACEUTICALLY ACCEPTABLE SALT OF THIS, FOR THE PREPARATION OF A MEDICINAL PRODUCT TO REGULATE THE LEVEL OF POTASSIUM IN THE BLOOD
Use of 10 - [(3r) -1-azabicyclo] oct-3-ylmethyl] -10-h-phenothiazine, or one of its pharmaceutically acceptable salts for the preparation of a useful medicine to prevent or treat obstructive bronchopneumopathy.
PHARMACEUTICAL COMPOSITION THAT INCLUDES A POWDER FOR ORAL SUSPENSION OF TACROLIMUS OR ONE OF ITS SALTS, HYDRATES OR SOLVATOS AND EXCIPIENTS PHARMACEUTICALLY ACCEPTABLE; PROCEDURE FOR PREPARATION OF SUCH PHARMACEUTICAL COMPOSITION; AND USE FOR PREVE